Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 22, 2026 20:24 UTC |
Younis HusamChief Scientific Officer
|
Tax withholdingCommon Stock | 11,216 | $8.95 | $100,383.20 |
DisclosureSEC source: 0001193125-26-397971 · ownership.xml · nonDerivative · entry 1 Younis Husam · CIK 0002107586 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,441 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:23 UTC |
Hughes Steven GeorgeChief Medical Officer
|
Tax withholdingCommon Stock | 21,459 | $8.95 | $192,058.05 |
DisclosureSEC source: 0001193125-26-397967 · ownership.xml · nonDerivative · entry 1 Hughes Steven George · CIK 0001747528 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,638 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:20 UTC |
Flanagan W. MichaelDirector
|
Tax withholdingCommon Stock | 22,812 | $8.95 | $204,167.40 |
DisclosureSEC source: 0001193125-26-397955 · ownership.xml · nonDerivative · entry 1 Flanagan W. Michael · CIK 0001841990 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,974 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:20 UTC |
Boyce SarahDirector
|
Tax withholdingCommon Stock | 126,418 | $8.95 | $1,131,441.10 |
DisclosureSEC source: 0001193125-26-397951 · ownership.xml · nonDerivative · entry 1 Boyce Sarah · CIK 0001629383 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,668 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:18 UTC |
Kenney StephanieSee Remarks
|
Tax withholdingCommon Stock | 2,375 | $8.95 | $21,256.25 |
DisclosureSEC source: 0001193125-26-397948 · ownership.xml · nonDerivative · entry 1 Kenney Stephanie · CIK 0002105422 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,085 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:17 UTC |
Gallagher Kathleen P.Director · See Remarks
|
Tax withholdingCommon Stock | 11,632 | $8.95 | $104,106.40 |
DisclosureSEC source: 0001193125-26-397944 · ownership.xml · nonDerivative · entry 1 Gallagher Kathleen P. · CIK 0002048409 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,729 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:17 UTC |
Winslow Brendan R.Chief Financial Officer
|
Tax withholdingCommon Stock | 6,742 | $8.95 | $60,340.90 |
DisclosureSEC source: 0001193125-26-397941 · ownership.xml · nonDerivative · entry 1 Winslow Brendan R. · CIK 0002105552 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,859 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:15 UTC |
Hoyos Rocio MartinChief Strategy Officer
|
Tax withholdingCommon Stock | 8,320 | $8.95 | $74,464.00 |
DisclosureSEC source: 0001193125-26-397936 · ownership.xml · nonDerivative · entry 1 Hoyos Rocio Martin · CIK 0002107515 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,340 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 17:54 UTC |
Hughes Steven GeorgeChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001193125-26-170963 · ownership.xml · derivative · entry 2 Hughes Steven George · CIK 0001747528 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-04-20 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 17:54 UTC |
Hughes Steven GeorgeChief Medical Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-170963 · ownership.xml · nonDerivative · entry 1 Hughes Steven George · CIK 0001747528 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,097 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 17:43 UTC |
Gallagher Kathleen P.Director · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 205,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001193125-26-170914 · ownership.xml · derivative · entry 2 Gallagher Kathleen P. · CIK 0002048409 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2036-04-20 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 17:43 UTC |
Gallagher Kathleen P.Director · See Remarks
|
GrantCommon Stock | 102,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-170914 · ownership.xml · nonDerivative · entry 1 Gallagher Kathleen P. · CIK 0002048409 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,361 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:54 UTC |
Kenney StephanieSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001193125-26-170964 · ownership.xml · derivative · entry 2 Kenney Stephanie · CIK 0002105422 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-04-20 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:54 UTC |
Kenney StephanieSee Remarks
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-170964 · ownership.xml · nonDerivative · entry 1 Kenney Stephanie · CIK 0002105422 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,460 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:53 UTC |
Winslow Brendan R.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001193125-26-170960 · ownership.xml · derivative · entry 2 Winslow Brendan R. · CIK 0002105552 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-04-20 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:53 UTC |
Winslow Brendan R.Chief Financial Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-170960 · ownership.xml · nonDerivative · entry 1 Winslow Brendan R. · CIK 0002105552 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,601 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:41 UTC |
Hoyos Rocio MartinChief Strategy Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001193125-26-170907 · ownership.xml · derivative · entry 2 Hoyos Rocio Martin · CIK 0002107515 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-04-20 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:41 UTC |
Hoyos Rocio MartinChief Strategy Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-170907 · ownership.xml · nonDerivative · entry 1 Hoyos Rocio Martin · CIK 0002107515 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,660 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:40 UTC |
Younis HusamChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001193125-26-170906 · ownership.xml · derivative · entry 2 Younis Husam · CIK 0002107586 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-04-20 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:40 UTC |
Younis HusamChief Scientific Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-170906 · ownership.xml · nonDerivative · entry 1 Younis Husam · CIK 0002107586 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,657 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:00 UTC |
Skerjanec SimonaDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001193125-26-085918 · ownership.xml · derivative · entry 1 Skerjanec Simona · CIK 0002022163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:00 UTC |
Boyce SarahDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001193125-26-085922 · ownership.xml · derivative · entry 1 Boyce Sarah · CIK 0001629383 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:00 UTC |
BOESS CARSTENDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001193125-26-085921 · ownership.xml · derivative · entry 1 BOESS CARSTEN · CIK 0001277495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:00 UTC |
WILSON TROY EDWARDDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001193125-26-085920 · ownership.xml · derivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 18:00 UTC |
Flanagan W. MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001193125-26-085919 · ownership.xml · derivative · entry 1 Flanagan W. Michael · CIK 0001841990 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.